The clinical trial is set to begin in weeks
The U.S. military has developed a universal vaccine against corona – a single dose that will block any existing or future strain. The clinical trial is set to begin within weeks, scientists at the Walter Reed Military Research Institute expect to announce effective vaccine development against all corona strains, even omicron as well as viral Previous corona such as SARS which have killed millions of people around the world.
The achievement is the result of almost two years of work on the virus. The military laboratory received the first DNA sequence of the corona virus in early 2020. At a very early stage, the infectious disease branch of the military institute decided to focus on producing a vaccine that would work not only against the existing strain of the virus but against all its possible strains.
The Walter Reed Spike Ferritin Nanoparticle COVID-19 vaccine, or SpFN, completed the animal testing phase earlier this year with positive results. Phase 1 of the human trial, which tested the vaccine against the omicron and other strains, ended this month, again with positive results that are undergoing a final review, said Dr. Kayvon Modjarrad, director of Walter Reed’s infectious diseases industry, in an exclusive interview.
Unlike existing vaccines, Walter Reed’s SpFN vaccine uses a 24-sided football-shaped protein. Allowing scientists to pin the “thorns” of different corona strains to different sides of the protein.
“It’s very exciting for our team, to get to that point and I think for the whole army as well,” Modjarrad said.